A similarity model for the human angiogenic factor, thymidine phosphorylase/platelet derived-endothelial cell growth factor

Anti-Cancer Drug Design

Volumn 14, Issue 5, 1999, Pages 411-420

  Cole, Christian ^a   Marks, Deborah S ^a   Jaffar, Mohammed ^a   Stratford, Ian J ^a   Douglas, Kenneth T ^a   Freeman, Sally ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Angiogenesis; Docking; Inhibitors; Oxycarbenium ion; PD ECGF; Similarity modelling; Thymidine phosphorylase

Indexed keywords

5 CHLORO 6 [1 (2 IMINOPYRROLIDINYL)METHYL]URACIL; ANGIOGENIC FACTOR; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; THYMIDINE; THYMIDINE PHOSPHORYLASE; THYMINE; UNCLASSIFIED DRUG; URACIL DERIVATIVE;

ALGORITHM; ARTICLE; CRYSTAL STRUCTURE; DRUG BINDING; ENZYME CONFORMATION; ESCHERICHIA COLI; MOLECULAR MODEL; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ENZYME INHIBITORS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN BINDING; SEQUENCE HOMOLOGY, AMINO ACID; THYMIDINE PHOSPHORYLASE;

ESCHERICHIA COLI;

EID: 0033504249     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Research, 25, 3389.
2. Asai K., Nakanishi K., Isobe I., Eksioglu Y.Z., Hirano A., Hama K., Miyamoto T., Kato T. (1992) Neurotrophic action of gliostatin on cortical neurons. Identity of gliostatin and platelet-derived endothelial cell growth factor. The Journal of Biological Chemistry, 267, 20311.
3. Bicknell R., Moghaddam A., Zhang H.T., Harris A.L., Hu D.-E., Fan T.P. (1994) Thymidine phosphorylase, platelet-derived endothelial cell growth factor and tumour angiogenesis. Proceedings of the American Association for Cancer Research, 35, 567.
4. Bleasby A.J., Akrigg D., Attwood T.K. (1994) OWL - a non-redundant, composite protein sequence database. Nucleic Acids Research, 22, 3574.
5. Bolin J.T., Filman D.J., Matthews D.A., Hamlin R.C., Kraut J. (1982) Crystal structures of Escherichia coli and Lactobacillus casei dihydrofolate reductase refined at 1.7 Å resolution. The Journal of Biological Chemistry, 257, 13650.
6. Brooks B.R., Bruccoleri R.E., Olafson B.D., States D.J., Swaminathan S., Karplus M. (1983) CHARMm: a program for macromolecular energy, minimization, and dynamics calculations. Journal of Computational Chemistry, 4, 187.
7. Brown N.S., Bicknell R. (1998) Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis. Biochemistry Journal, 334, 1.
8. Chekhlov A.N. (1995) Intramolecular C-HO interactions in the main nucleosides from crystallographic data. Refinement of the crystal structure of thymidine. Zhurnal Strukturnoi Khimii, 36, 178.
9. Corpet F. (1994) Multiple sequence alignment with hierarchical clustering. Nucleic Acids Research, 16, 10881.
10. Dada M.A., Boshoff C.H., Turley M.A., Schneider J.W., Chetty R., Gatter K.C. (1996) Thymidine phosphorylase expression in Kaposi sarcoma. Journal of Clinical Pathology, 49, 400.
11. Desgranges C., Razaka G., Rabaud M., Bricaud H. (1981) Catabolism of thymidine in human blood platelets. Purification and properties of thymidine phosphorylase. Biochimica et Biophysica Acta, 654, 211.
12. Duax W.L., Norton D.A. (1975) Atlas of Steroid Structure. Plenum Press: New York.
13. Erion M.D., Stoeckler J.D., Guida W.C., Walter R.L., Ealick S.E. (1997) Purine nucleoside phosphorylase. 2. Catalytic mechanism. Biochemistry, 36, 11735.
14. Fehlhammer H., Bode W. (1975) The refined crystal structure of bovine β-trypsin at 1.8 Å resolution. Journal of Molecular Biology, 98, 683.
15. Finnis C., Dodsworth N, Pollitt C.E., Carr G., Sleep D. (1993) Thymidine phosphorylase activity of platelet-derived endothelial cell growth factor is responsible for endothelial cell mitogenicity. European Journal of Biochemistry, 212, 201.
16. Furukawa T., Yoshimura A., Sumizawa T., Haraguchi M., Akiyama S.-I., Fukui K., Ishizawa M., Yamada Y. (1992) Angiogenic factor. Nature, 356, 668.
17. Griffiths L., Stratford I.J. (1997) Platelet-derived endothelial cell growth factor/thymidine phosphorylase in tumour growth and response to therapy. British Journal of Cancer, 76, 689.
18. Halgren T.A. (1992) Representation of van der Waals (vdW) interactions in molecular mechanics force fields: potential form, combination rules, and vdW parameters. Journal of the American Chemical Society, 114, 7827.
19. Haraguchi M., Miyadera K., Uemura K., Sumizawa T., Furukawa T., Yamada K., Akiyama S.-I., Yamada Y. (1994) Angiogenic activity of enzymes. Nature, 368, 198.
20. Ishikawa F., Miyazono K., Hellman U., Drexler H., Wernstedt C., Hagiwara K., Usuki K., Takaku F., Risau W, Heldin C.-H. (1989) Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature, 338, 557.
21. Ishikawa T., Sekiguchi F., Fukase Y., Sawada N., Ishitsuka H. (1998) Positive correlation between the efficacy of Capecitabine and Doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts. Cancer Research, 58, 685.
22. Kono A., Hara Y., Matsushima Y. (1981) Enzymatic function of 5-fluorouracil from 1-(tetrahydro-2-furanyl)-5-fluorouracil (Tegafur) in human tumor tissues. Chemical and Pharmaceutical Bulletin, 29, 1486.
23. Kono A., Hara Y., Sugata S., Karube Y., Matsushima Y., Ishitsuka H. (1983) Activation of 5′-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors. Chemical and Pharmaceutical Bulletin, 31, 175.
24. Kono A., Hara Y., Sugata S., Matsushima Y., Ueda T. (1984) Substrate specificity of thymidine phosphorylase in human liver tumor. Chemical and Pharmaceutical Bulletin, 32, 1919.
25. Langen P., Etzold G., Bärwolff D., Preussel B. (1967) Inhibition of thymidine phosphorylase by 6-aminothymine and derivatives of 6-aminouracil. Biochemical Pharmacology, 16, 1833.
26. Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M. (1993) PROCHECK: a program to check the stereo-chemical quality of protein structure. Journal of Applied Crystallography, 26, 283.
27. Luccioni C., Beaumartin J., Bardot V., Lefrançois D. (1994) Pyrimidine nucleotide metabolism in human colon carcinomas: comparison of normal tissues, primary tumors and xenografts. International Journal of Cancer, 58, 517.
28. Niedzwicki J.G., El Kouni M.H., Chu S.H., Cha S. (1983) Structure-activity relationship of ligands of the pyrimidine nucleoside phosphorylases. Biochemical Pharmacology, 32, 399.
29. Pugmire M.J., Cook W.J., Jasanoff A., Walter M.R., Ealick S.E. (1998) Structural and theoretical studies suggest domain movement produces an active conformation of thymidine phosphorylase. Journal of Molecular Biology, 281, 285.
30. Pugmire M.J., Ealick S.E. (1998) The crystal structure of pyrimidine nucleoside phosphorylase in a closed conformation. Structure, 6, 1467.
31. Rost B., Sander C. (1993) Prediction of protein structure at better than 70% accuracy. Journal of Molecular Biology, 232, 584.
32. Rost B., Sander C. (1994) Combining evolutionary information and neural networks to predict protein secondary structure. Proteins, 19, 55.
33. Rost B., Sander C., Schneider R. (1994) PHD - an automatic mail server for protein secondary structure prediction. Computer Applications in the Biosciences, 10, 53.
34. Sumizawa T., Furukawa T., Haraguchi M., Yoshimura A., Takeyasu A., Ishikawa M., Yamada Y., Akiyama S.-I. (1993) Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor. Journal of Biochemistry, 114, 9.
35. Suzuki N., Fukushima M., Asao T., Yamada Y., Akiyama S. (1997) Invention of a novel antitumor agent, TAS-102. Antitumor activities of 5-trifluorothymidine combined with a new inhibitor of thymidine phosphorylase. Proceedings of the American Association for Cancer Research, 38, 101.
36. Toi M., Hoshina S., Taniguchi T., Yamamoto Y., Ishitsuka H., Tominaga T. (1995) Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. International Journal of Cancer, 64, 79.
37. Usuki K., Saras J., Waltenberger J., Miyazono K., Pierce G., Thomason A., Heldin C.-H. (1992) Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity. Biochemical and Biophysical Research Communications, 184, 1311.
38. Walter M.R., Cook W.J., Cole L.B., Short S.A., Koszalka G.W., Krenitsky T.A., Ealick S.E. (1990) Three-dimensional structure of thymidine phosphorylase from Escherichia coli at 2.8 Å resolution. The Journal of Biological Chemistry, 265, 14016.
39. Yano S., Tada Y., Kazuno H., Sato T., Tamashita J., Suzuki N., Emura T., Fukushima M., Asao T. (1996) Uracil derivatives, and antitumor effect potentiator and antitumor containing the same. PCT Int. Appl. WO96/30346.